Clinical Trials on CDNKN2A Loss Defined in Liechtenstein
Total 0 results
Nothing found
Sponsors and Collaborators
- Donna Hammond, PhD
- University of Natural Resources and Life Sciences, Vienna, Austria
- Institute of Antibiotics, Huashan Hospital, Fudan University
- Cooperative Clinical Drug Research and Development AG (CCDRD AG)
- Delosis Limited
- Centre Hospitalier de Bastia
- IDRI Corporation
- Prof. Jürgen Kuschyk, M.D
- RINO ZUID
- Shamir Optical Industry Ltd
- Jikei University School of Medicine
- Research Unit of General Practice, Odense
- Deutsche Arthrose-Hilfe
- Stefania Basili
- Canadian Hemophilia Society
- The First Affiliated Hospital of Air Force Medicial University
- Faculdade de Medicina da Universidade do Porto (FMUP)
- InfraScan, Inc.
- Jiajie Chen
- Alfred Hospital Intensive Care Unit Australia
- View Full List
Medical Conditions
- Neovascular Age-related Macular Degeneration(nAMD)
- Subgluteal Sciatic Block
- UP in Online Group Format
- Oxidative Stress in Patient With Haemoglobinopathy and Affect it of Endocrine System
- HIV Related Insulin Resistance
- Asian Consortium
- Ovarian Aging
- Colonic Adenoma
- Refractory Transformed B-Cell Non-Hodgkin Lymphoma
- Open Reduction and Internal Fixation
- Insulin-Dependent Diabetes Mellitus
- Robot-assisted Laparoscopic Prostatectomy Under General Anesthesia
- Autosomal Dominant Hypocalcaemia
- Sensory Reconstruction of Digits
- Community-Acquired Staphylococcus Aureus
- Acute Myocardial Infarction, of Inferolateral Wall
- Reduction, Weight
- Surgery Induced Tissue Adhesions
- Incompetence, Functional
- Sepsis and Coagulopathy
- View Full List
Drug Interventions
- JR-141
- Prucalopride
- Rosuvastatin calcium tablets
- Domperidone
- Chlorcyclizine HCl
- INCB7839
- Nanoliposomal Irinotecan
- Gemcitabine (mg/m²)
- Radioligand (11C)AZD2184
- Atorvastatin, 10mg, 20mg, 40mg
- HLX23
- Sorafenib and OSI-906
- Moxifloxacin
- PF regimen (cis-platinum ; 5-fluorouracil ) combined with PD-1 inhibitors（pembrolizumab）
- LIS 18 U
- Epoetin beta (NeoRecormon®)
- Arm 1 - GEH120714 (18F) Injection
- 13 valent pneumococcal conjugate vaccine and 23 valent pneumococcal polysaccharide vaccine
- Propranolol Hydrochloride Extended Release Capsules 160 mg
- Hypertonic saline
- View Full List
CROs by country
- Contract Research Organizations in Armenia
- Contract Research Organizations in Cote d'Ivoire
- Contract Research Organizations in Djibouti
- Contract Research Organizations in Equatorial Guinea
- Contract Research Organizations in Germany
- Contract Research Organizations in Ghana
- Contract Research Organizations in Indonesia
- Contract Research Organizations in Malta
- Contract Research Organizations in Myanmar
- Contract Research Organizations in Poland
- Contract Research Organizations in Saudi Arabia
- Contract Research Organizations in Sweden
- Contract Research Organizations in Tanzania
- CRO list by country